The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.1048C>T (p.Arg350Ter)

CA031387

226342 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: bf884b04-1e33-40c4-997c-e13fd8755871

HGVS expressions

NM_000527.5:c.1048C>T
NM_000527.5(LDLR):c.1048C>T (p.Arg350Ter)
NC_000019.10:g.11110759C>T
CM000681.2:g.11110759C>T
NC_000019.9:g.11221435C>T
CM000681.1:g.11221435C>T
NC_000019.8:g.11082435C>T
NG_009060.1:g.26379C>T
ENST00000558518.6:c.1048C>T
ENST00000252444.9:n.1302C>T
ENST00000455727.6:c.544C>T
ENST00000535915.5:c.925C>T
ENST00000545707.5:c.667C>T
ENST00000557933.5:c.1048C>T
ENST00000558013.5:c.1048C>T
ENST00000558518.5:c.1048C>T
ENST00000560173.1:n.47C>T
ENST00000560467.1:n.541-755C>T
NM_000527.4:c.1048C>T
NM_001195798.1:c.1048C>T
NM_001195799.1:c.925C>T
NM_001195800.1:c.544C>T
NM_001195803.1:c.667C>T
NM_001195798.2:c.1048C>T
NM_001195799.2:c.925C>T
NM_001195800.2:c.544C>T
NM_001195803.2:c.667C>T

Pathogenic

Met criteria codes 5
PS4 PM2 PP1_Strong PVS1 PP4
Not Met criteria codes 2
PS3 BS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5 (LDLR):c.1048C>T(p.Arg350Ter) variant is classified as Pathogenic for Familial Hypercholesterolemia by applying evidence codes (PM2, PVS1, PP4, PS4, PP1_Strong) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2: PopMax MAF = 0.00005 in East Asian population in gnomAD (gnomAD v2.1.1). PVS1: The variant causing a premature stop codon amino-terminal of amino acid 830 (NM_000527.5:p.Lys830). PP4: This variant meets PM2 and is identified in >1 index case who met clinical criteria for FH after alternative causes for high cholesterol were excluded. PS4: Variant meets PM2 and is identified in 23 unrelated index cases fulfil clinical criteria for FH. Ten cases fulfil Simon Broome FH criteria (5 cases from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies , APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière; 3 cases from Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, PMID 22698793; 1 case from Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge; 1 case from Division of Cardiology, Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan (PMID 20538126)). Thirteen cases fulfil DLCN criteria (10 cases from Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA; 1 case each from Lipid Clinic, Fundación Jiménez Díaz, Madrid, Spain (PMID 19318025); Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland (PMID 9654205); GeneDx). PP1_Strong: Variant segregates with FH phenotype in 20 informative meiosis from at least 11 families. Fifteen affected relatives tested positive for the variant from at least 6 families from 4 different labs (Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies , APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière; Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation; GeneDx; Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA). Five unaffected relatives tested negative for the variant from 5 families (Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA).
Met criteria codes
PS4
Variant meets PM2 and is identified in 23 unrelated index cases fulfil clinical criteria for FH. Ten cases fulfil Simon Broome FH criteria (5 cases from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies , APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière; 3 cases from Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, PMID 22698793; 1 case from Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge; 1 case from Division of Cardiology, Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan (PMID 20538126)). Thirteen cases fulfil DLCN criteria (10 cases from Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA; 1 case each from Lipid Clinic, Fundación Jiménez Díaz, Madrid, Spain (PMID 19318025); Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland (PMID 9654205); GeneDx).
PM2
PopMax MAF = 0.00005 in East Asian population in gnomAD (gnomAD v2.1.1).
PP1_Strong
Variant segregates with FH phenotype in 20 informative meiosis from at least 11 families. Fifteen affected relatives tested positive for the variant from at least 6 families from 4 different labs (Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies , APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière; Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation; GeneDx; Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA). Five unaffected relatives tested negative for the variant from 5 families (Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA).
PVS1
The variant causing a premature stop codon amino-terminal of amino acid 830 (NM_000527.5:p.Lys830).
PP4
This variant meets PM2 and is identified in >1 index case who met clinical criteria for FH after alternative causes for high cholesterol were excluded.
Not Met criteria codes
PS3
Functional data is not available.
BS4
Variant does not segregate with FH phenotype in 3 relatives in 3 families from 3 different labs. Three affected relatives tested negative for the variant, 1 case each from: Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation; Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA; Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge. However, there is no instance where unaffected family member carry the variant. Therefore BS4 is not met.
Approved on: 2022-03-25
Published on: 2022-04-25
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.